Quick Answer
Medpace Holdings, Inc. reported Stockholders Equity of $459.07 million for the year ending 2025.
- Medpace Holdings, Inc. showed a decrease of -44.4% in Stockholders Equity from 2024 to 2025.
- This data is from Medpace Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 10, 2026.
- XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $610.54 million | Q1 2017: $620.98 million | Q2 2017: $607.36 million | Q3 2017: $550.25 million | Q1 2018: $526.47 million | Q2 2018: $543.13 million | Q3 2018: $564.44 million | Q1 2019: $621.90 million | Q2 2019: $658.06 million | Q3 2019: $692.01 million | Q1 2020: $717.80 million | Q2 2020: $738.07 million | Q3 2020: $791.63 million | Q1 2021: $858.93 million | Q2 2021: $851.88 million | Q3 2021: $898.09 million | Q1 2022: $605.02 million | Q2 2022: $283.25 million | Q3 2022: $349.89 million | Q1 2023: $347.26 million | Q2 2023: $391.06 million | Q3 2023: $470.91 million | Q1 2024: $671.54 million | Q2 2024: $763.60 million | Q3 2024: $881.44 million | Q1 2025: $593.61 million | Q2 2025: $172.35 million | Q3 2025: $293.64 million.
- Over the full 13 years of available data (2014 to 2025), Medpace Holdings, Inc.'s Stockholders Equity has grown by 10.9%.
- Historical annual values: Fiscal year 2025: $459.07 million | Fiscal year 2024: $825.55 million | Fiscal year 2023: $558.95 million | Fiscal year 2022: $386.39 million | Fiscal year 2021: $952.93 million | Fiscal year 2020: $805.78 million | Fiscal year 2019: $726.28 million | Fiscal year 2018: $598.86 million | Fiscal year 2017: $509.26 million | Fiscal year 2016: $610.71 million | Fiscal year 2015: $413.47 million | Fiscal year 2014: $401.97 million | Fiscal year 2014: $414.00 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: